Tango Therapeutics (TNGX) Accounts Payables (2020 - 2026)

Tango Therapeutics' Accounts Payables history runs 7 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 24.98% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (down 24.98% YoY), while the FY2025 annual figure was $1.2 million, down 26.17% from the prior year.
• Accounts Payables was $2.4 million for Q1 2026 at Tango Therapeutics, up from $1.2 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $6.3 million in Q3 2022 to a low of $1.1 million in Q2 2024.
• Historically, Accounts Payables has averaged $3.2 million across 5 years, with a median of $2.8 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Accounts Payables jumped 6342.41% in 2022, then sank 77.84% in 2024.
• A 5-year view of Accounts Payables shows it stood at $4.5 million in 2022, then slumped by 37.46% to $2.8 million in 2023, then plunged by 42.51% to $1.6 million in 2024, then slipped by 26.17% to $1.2 million in 2025, then jumped by 105.58% to $2.4 million in 2026.
• The last three Accounts Payables figures came in at $2.4 million (Q1 2026), $1.2 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.